Cerivastatin (BAY w 6228):: A novel HMG-CoA reductase inhibitor

被引：17
作者：
Kuhlmann, J
Mück, W
Bischoff, H
von Keutz, E
Llewellyn, M
机构：
[1] Bayer AG, Pharma Res Ctr, Inst Clin Pharmacol, D-42096 Wuppertal, Germany
[2] Bayer PLC, European Med Affairs, Stoke Court, England
来源：
CARDIOVASCULAR DRUG REVIEWS | 1998年 / 16卷 / 03期
关键词：
hypercholesterolemia; cerivastatin; HMG-CoA-reductase inhibitors; pharmacology; toxicology; clinical pharmacology;
D O I：
10.1111/j.1527-3466.1998.tb00357.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236 / 263
页数：28
相关论文
共 74 条
[1]   MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
[2]   CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY [J].
ANDERSON, KM ;
CASTELLI, WP ;
LEVY, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16) :2176-2180
[3]  
Angerbauer R., 1994, Drugs of the Future, V19, P537
[4]  
AZUMA J, 1996, JPN PHARM THER S9, V24, P55
[5]  
AZUMA J, 1996, JPN PHARM THER S9, V24, P37
[6]  
Azuma J, 1996, JPN PHARM THER S9, V24, P29
[7]   Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor [J].
Bischoff, H ;
Angerbauer, R ;
Bender, J ;
Bischoff, E ;
Faggiotto, A ;
Petzinna, D ;
Pfitzner, J ;
Porter, MC ;
Schmidt, D ;
Thomas, G .
ATHEROSCLEROSIS, 1997, 135 (01) :119-130
[8]  
BISCHOFF H, 1997, ATHEROSCLEROSIS SUPP, V130, pS25
[9]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[10]  
Boberg M, 1997, DRUG METAB DISPOS, V25, P321
12345678